Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Knapp

Showing results (651-660 of 689) with videos related to

Pageof 69
Sort By:
European Urology|July 25, 2007
Sentinel lymph node mapping of invasive urinary bladder cancer in animal models using invisible lightDeborah W Knapp, Larry G Adams, Alec M Degrand, et al.
Oncotarget|May 4, 2018
Near infrared photoimmunotherapy targeting bladder cancer with a canine anti-epidermal growth factor receptor (EGFR) antibodyTadanobu Nagaya, Shuhei Okuyama, Fusa Ogata, et al.
Journal of the American Veterinary Medical Association|May 21, 2013
Metronomic administration of chlorambucil for treatment of dogs with urinary bladder transitional cell carcinomaDiane R Schrempp, Michael O Childress, Jane C Stewart, et al.
Cancer Chemotherapy and Pharmacology|October 6, 2000
Cisplatin versus cisplatin combined with piroxicam in a canine model of human invasive urinary bladder cancerD W Knapp, N W Glickman, W R Widmer, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 25, 2005
Pretreatment tumor prostaglandin E2 concentration and cyclooxygenase-2 expression are not associated with the response of canine naturally occurring invasive urinary bladder cancer to cyclooxygenase inhibitor therapyA J Mutsaers, S I Mohammed, D B DeNicola, et al.
Plos One|December 17, 2024
Beneficial modulation of the gut microbiome by leachates of Penicillium purpurogenum in the presence of clays: A model for the preparation and efficacy of historical Lemnian EarthSimon Milling, Umer Zeeshan Ijaz, Danae Venieri, et al.
The Science of the Total Environment|April 16, 2013
Detection of herbicides in the urine of pet dogs following home lawn chemical applicationDeborah W Knapp, Wendy A Peer, Abass Conteh, et al.
Frontiers in Veterinary Science|November 15, 2021
High Prevalence and Factors Associated With the Distribution of the Integron <i>intI1</i> and <i>intI2</i> Genes in Scottish Cattle HerdsCristina Fernández Rivas, Thibaud Porphyre, Margo E Chase-Topping, et al.
Journal of the American Veterinary Medical Association|July 30, 2019
Pathology in PracticeAshley L Leisering, Mario F Sola, Lisbeth A Ambrosius, et al.
Molecular Cancer Therapeutics|February 18, 2003
Effects of the cyclooxygenase inhibitor, piroxicam, in combination with chemotherapy on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancerSulma I Mohammed, Bruce A Craig, Anthony J Mutsaers, et al.
Pageof 69

Showing results (651-660 of 689) with videos related to

Sort By:
Pageof 69
European Urology|July 25, 2007
Sentinel lymph node mapping of invasive urinary bladder cancer in animal models using invisible lightDeborah W Knapp, Larry G Adams, Alec M Degrand, et al.
Oncotarget|May 4, 2018
Near infrared photoimmunotherapy targeting bladder cancer with a canine anti-epidermal growth factor receptor (EGFR) antibodyTadanobu Nagaya, Shuhei Okuyama, Fusa Ogata, et al.
Journal of the American Veterinary Medical Association|May 21, 2013
Metronomic administration of chlorambucil for treatment of dogs with urinary bladder transitional cell carcinomaDiane R Schrempp, Michael O Childress, Jane C Stewart, et al.
Cancer Chemotherapy and Pharmacology|October 6, 2000
Cisplatin versus cisplatin combined with piroxicam in a canine model of human invasive urinary bladder cancerD W Knapp, N W Glickman, W R Widmer, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 25, 2005
Pretreatment tumor prostaglandin E2 concentration and cyclooxygenase-2 expression are not associated with the response of canine naturally occurring invasive urinary bladder cancer to cyclooxygenase inhibitor therapyA J Mutsaers, S I Mohammed, D B DeNicola, et al.
Plos One|December 17, 2024
Beneficial modulation of the gut microbiome by leachates of Penicillium purpurogenum in the presence of clays: A model for the preparation and efficacy of historical Lemnian EarthSimon Milling, Umer Zeeshan Ijaz, Danae Venieri, et al.
The Science of the Total Environment|April 16, 2013
Detection of herbicides in the urine of pet dogs following home lawn chemical applicationDeborah W Knapp, Wendy A Peer, Abass Conteh, et al.
Frontiers in Veterinary Science|November 15, 2021
High Prevalence and Factors Associated With the Distribution of the Integron <i>intI1</i> and <i>intI2</i> Genes in Scottish Cattle HerdsCristina Fernández Rivas, Thibaud Porphyre, Margo E Chase-Topping, et al.
Journal of the American Veterinary Medical Association|July 30, 2019
Pathology in PracticeAshley L Leisering, Mario F Sola, Lisbeth A Ambrosius, et al.
Molecular Cancer Therapeutics|February 18, 2003
Effects of the cyclooxygenase inhibitor, piroxicam, in combination with chemotherapy on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancerSulma I Mohammed, Bruce A Craig, Anthony J Mutsaers, et al.
Pageof 69